Celltrion Pharm Inc Cash Flow Quality Index
Celltrion Pharm Inc cash flow quality index. Celltrion Pharm Inc (068760) has a Cash Flow Quality Index of 2.05x as of September 2025. Operating cash flow of ₩23.44 Billion exceeds net income of ₩11.46 Billion, indicating high earnings quality where cash backs reported profits. See Celltrion Pharm Inc (068760) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Celltrion Pharm Inc (2014–2024)
Cash flow quality index of Celltrion Pharm Inc from 2014 to 2024. Historical Cash Flow Quality Index for Celltrion Pharm Inc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 068760 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Celltrion Pharm Inc Cash Flow Quality Index by Year (2014–2024)
Celltrion Pharm Inc cash flow quality index by year from 2014 to 2024. Year-by-year earnings quality comparison for Celltrion Pharm Inc. For the full cash flow conversion analysis, see 068760 operating cash flow.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.58x | ₩56.59 Billion | ₩21.97 Billion | ▲ +525.6% |
| 2023 | 0.41x | ₩8.76 Billion | ₩21.26 Billion | ▲ +364.2% |
| 2022 | -0.16x | ₩-4.05 Billion | ₩25.96 Billion | ▼ -105.8% |
| 2021 | 2.69x | ₩93.15 Billion | ₩34.58 Billion | ▲ +55.6% |
| 2020 | 1.73x | ₩36.25 Billion | ₩20.94 Billion | ▼ -46.5% |
| 2019 | 3.24x | ₩27.85 Billion | ₩8.60 Billion | ▲ +162.1% |
| 2016 | -5.22x | ₩-15.21 Billion | ₩2.92 Billion | ▼ -362.9% |
| 2015 | 1.98x | ₩13.36 Billion | ₩6.73 Billion | ▼ -32.8% |
| 2014 | 2.95x | ₩17.33 Billion | ₩5.87 Billion | — |